Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
The latest announcement is out from Qualigen Therapeutics ( (QLGN) ).
Matt Korenberg resigned immediately as the chairman of the audit committee and independent member of Qualigen Therapeutics’ Board on October 3, 2024, with no disagreements cited regarding company operations or policies. Shortly after, on October 8, Braeden Lichti, an experienced entrepreneur with ties to several investment and advisory companies, was appointed as an independent member of the Board. Additionally, Robert Lim was named the new chairperson of the Audit Committee.
Learn more about QLGN stock on TipRanks’ Stock Analysis page.
